These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

121 related articles for article (PubMed ID: 26692472)

  • 1. First characterization of fluoroquinolone resistance mechanisms in CTX-M-producing Escherichia coli from Mongolia.
    Kao CY; Udval U; Wu HM; Bolormaa E; Yan JJ; Khosbayar T; Wu JJ
    Infect Genet Evol; 2016 Mar; 38():79-81. PubMed ID: 26692472
    [No Abstract]   [Full Text] [Related]  

  • 2. Molecular characterization of extended-spectrum β-lactamase-producing Escherichia coli and Klebsiella spp. isolates in Mongolia.
    Kao CY; Udval U; Huang YT; Wu HM; Huang AH; Bolormaa E; Yan JJ; Urangoo Z; Batbaatar G; Khosbayar T; Wu JJ
    J Microbiol Immunol Infect; 2016 Oct; 49(5):692-700. PubMed ID: 26194952
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Occurrence of the Plasmid-Mediated Fluoroquinolone Resistance qepA1 Gene in Two Clonal Clinical Isolates of CTX-M-15-Producing Escherichia coli from Algeria.
    Yanat B; Dali Yahia R; Yazi L; Machuca J; Díaz-De-Alba P; Touati A; Pascual Á; Rodríguez-Martínez JM
    Microb Drug Resist; 2017 Jun; 23(4):497-499. PubMed ID: 27736309
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Fluoroquinolone-resistant and extended-spectrum β-lactamase-producing Escherichia coli from the milk of cows with clinical mastitis in Southern Taiwan.
    Su Y; Yu CY; Tsai Y; Wang SH; Lee C; Chu C
    J Microbiol Immunol Infect; 2016 Dec; 49(6):892-901. PubMed ID: 25592882
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Prevalence of fluoroquinolone-resistant Escherichia coli O25:H4-ST131 (CTX-M-15-nonproducing) strains isolated in Japan.
    Yokota S; Sato T; Okubo T; Ohkoshi Y; Okabayashi T; Kuwahara O; Tamura Y; Fujii N
    Chemotherapy; 2012; 58(1):52-9. PubMed ID: 22343392
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Detection of plasmid-mediated quinolone resistance associated with qnrA in an Escherichia coli clinical isolate producing CTX-M-9 beta-lactamase in Japan.
    Saito R; Kumita W; Sato K; Chida T; Okamura N; Moriya K; Koike K
    Int J Antimicrob Agents; 2007 May; 29(5):600-2. PubMed ID: 17239568
    [No Abstract]   [Full Text] [Related]  

  • 7. Characterization of extended-spectrum beta-lactamases produced by Escherichia coli isolated from hospitalized and nonhospitalized patients: emergence of CTX-M-15-producing strains causing urinary tract infections.
    Smet A; Martel A; Persoons D; Dewulf J; Heyndrickx M; Claeys G; Lontie M; Van Meensel B; Herman L; Haesebrouck F; Butaye P
    Microb Drug Resist; 2010 Jun; 16(2):129-34. PubMed ID: 20370505
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Biochemical characterization of CTX-M-166, a new CTX-M β-lactamase produced by a commensal Escherichia coli isolate.
    Manageiro V; Graça R; Ferreira E; Clemente L; Bonnet R; Caniça M
    J Antibiot (Tokyo); 2017 Jun; 70(6):809-810. PubMed ID: 28377638
    [No Abstract]   [Full Text] [Related]  

  • 9. Extraintestinal pathogenic Escherichia coli: an update on antimicrobial resistance, laboratory diagnosis and treatment.
    Pitout JD
    Expert Rev Anti Infect Ther; 2012 Oct; 10(10):1165-76. PubMed ID: 23199402
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Emergence of Escherichia coli ST131 sub-clone H30 producing VIM-1 and KPC-3 carbapenemases, Italy.
    Accogli M; Giani T; Monaco M; Giufrè M; García-Fernández A; Conte V; D'Ancona F; Pantosti A; Rossolini GM; Cerquetti M
    J Antimicrob Chemother; 2014 Aug; 69(8):2293-6. PubMed ID: 24797065
    [No Abstract]   [Full Text] [Related]  

  • 11. Prevalence of plasmid-mediated AmpC β-lactamase-producing Escherichia coli and spread of the ST131 clone among extended-spectrum β-lactamase-producing E. coli in Japan.
    Matsumura Y; Yamamoto M; Higuchi T; Komori T; Tsuboi F; Hayashi A; Sugimoto Y; Hotta G; Matsushima A; Nagao M; Takakura S; Ichiyama S
    Int J Antimicrob Agents; 2012 Aug; 40(2):158-62. PubMed ID: 22743014
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Diverse phenotypic and genotypic characterization among clinical Klebsiella pneumoniae and Escherichia coli isolates carrying plasmid-mediated quinolone resistance determinants.
    Yang J; Luo Y; Cui S; Wang W; Han L
    Microb Drug Resist; 2011 Sep; 17(3):363-7. PubMed ID: 21563956
    [TBL] [Abstract][Full Text] [Related]  

  • 13. High prevalence of ST131 among CTX-M-producing Escherichia coli from community-acquired infections, in the Czech Republic.
    Papagiannitsis CC; Študentová V; Jakubů V; Španělová P; Urbášková P; Žemličková H; Hrabák J
    Microb Drug Resist; 2015 Feb; 21(1):74-84. PubMed ID: 25188031
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Occurrence, prevalence and genetic environment of CTX-M beta-lactamases in Enterobacteriaceae from Indian hospitals.
    Ensor VM; Shahid M; Evans JT; Hawkey PM
    J Antimicrob Chemother; 2006 Dec; 58(6):1260-3. PubMed ID: 17071956
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Prevalence and distribution of plasmid-mediated quinolone resistance genes in clinical isolates of Escherichia coli lacking extended-spectrum beta-lactamases.
    Jones GL; Warren RE; Skidmore SJ; Davies VA; Gibreel T; Upton M
    J Antimicrob Chemother; 2008 Dec; 62(6):1245-51. PubMed ID: 18827034
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Identification of fluoroquinolone-resistant extended-spectrum β-lactamase (CTX-M-8)-producing Escherichia coli ST224, ST2179 and ST2308 in buffalo (Bubalus bubalis).
    Aizawa J; Neuwirt N; Barbato L; Neves PR; Leigue L; Padilha J; Pestana de Castro AF; Gregory L; Lincopan N
    J Antimicrob Chemother; 2014 Oct; 69(10):2866-9. PubMed ID: 24928853
    [No Abstract]   [Full Text] [Related]  

  • 17. Plasmid mediated quinolone resistance determinants qnr, aac(6')-Ib-cr, and qep in ESBL-producing Escherichia coli clinical isolates from Egypt.
    Hassan WM; Hashim A; Domany R
    Indian J Med Microbiol; 2012; 30(4):442-7. PubMed ID: 23183470
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Distribution of CTX-M group I and group III β-lactamases produced by Escherichia coli and klebsiella pneumoniae in Lahore, Pakistan.
    Abrar S; Vajeeha A; Ul-Ain N; Riaz S
    Microb Pathog; 2017 Feb; 103():8-12. PubMed ID: 27956216
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Mechanisms of resistance and mobility among multidrug-resistant CTX-M-producing Escherichia coli from Canadian intensive care units: the 1st report of QepA in North America.
    Baudry PJ; Nichol K; DeCorby M; Lagacé-Wiens P; Olivier E; Boyd D; Mulvey MR; Hoban DJ; Zhanel GG
    Diagn Microbiol Infect Dis; 2009 Mar; 63(3):319-26. PubMed ID: 19216943
    [TBL] [Abstract][Full Text] [Related]  

  • 20. A survey of plasmid-mediated fluoroquinolone resistance genes from Escherichia coli isolates and their dissemination in Shandong, China.
    Xia LN; Li L; Wu CM; Liu YQ; Tao XQ; Dai L; Qi YH; Lu LM; Shen JZ
    Foodborne Pathog Dis; 2010 Feb; 7(2):207-15. PubMed ID: 19911944
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.